[
  {
    "ts": null,
    "headline": "Regeneron to Report Q4 Earnings: Is a Beat in the Cards?",
    "summary": "Investors' focus is likely to be on the performance of Dupixent and the uptake of Eylea HD when REGN reports fourth-quarter 2024 results soon.",
    "url": "https://finnhub.io/api/news?id=ca424689774a91dd02ac66e6def0b0ee19ea72af00f138376970f0053b63c70d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738347660,
      "headline": "Regeneron to Report Q4 Earnings: Is a Beat in the Cards?",
      "id": 132601945,
      "image": "https://media.zenfs.com/en/zacks.com/004265dfd2737a0262868ee5a83c126c",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Investors' focus is likely to be on the performance of Dupixent and the uptake of Eylea HD when REGN reports fourth-quarter 2024 results soon.",
      "url": "https://finnhub.io/api/news?id=ca424689774a91dd02ac66e6def0b0ee19ea72af00f138376970f0053b63c70d"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=762a2a11bdf5de74de86886027ad88d04f58dd54fd0ecf5fabecc49c33e4e42d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738341780,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "id": 132526851,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=762a2a11bdf5de74de86886027ad88d04f58dd54fd0ecf5fabecc49c33e4e42d"
    }
  },
  {
    "ts": null,
    "headline": "Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in Regeneron Lawsuit - REGN",
    "summary": "NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=4943977030c984ca610af301c294c165c3867416e5499a6d2c75df197f130cab",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738302378,
      "headline": "Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in Regeneron Lawsuit - REGN",
      "id": 132503758,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=4943977030c984ca610af301c294c165c3867416e5499a6d2c75df197f130cab"
    }
  },
  {
    "ts": null,
    "headline": "It’s Bananas, but Stock Splits Can Pay Off. Here Are 5 Likely Contenders.",
    "summary": "It’s Bananas, but Stock Splits Can Pay Off. Here Are 5 Likely Contenders.",
    "url": "https://finnhub.io/api/news?id=2cd9207857ff44cd6d4ace04e323f1cbf6009cca73056b3b89d73d4ad847d0e9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738294200,
      "headline": "It’s Bananas, but Stock Splits Can Pay Off. Here Are 5 Likely Contenders.",
      "id": 134152123,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "It’s Bananas, but Stock Splits Can Pay Off. Here Are 5 Likely Contenders.",
      "url": "https://finnhub.io/api/news?id=2cd9207857ff44cd6d4ace04e323f1cbf6009cca73056b3b89d73d4ad847d0e9"
    }
  }
]